Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis.
about
Glucose metabolism in gastric cancer: The cutting-edgeMultimodal treatment of gastric cancer in the west: Where are we going?Imaging of Gastric Cancer Metabolism Using 18 F-FDG PET/CTApproaches and genetic determinants in predicting response to neoadjuvant chemotherapy in locally advanced gastric cancerImaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review.F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the staging of linitis plastica caused by primary gastric adenocarcinoma.Diagnosis and evaluation of gastric cancer by positron emission tomographyProteomic and metabolic prediction of response to therapy in gastric cancer.Redefining early gastric cancer.Correlation of Primary Tumor FDG Uptake with Histopathologic Features of Advanced Gastric Cancer.Proliferative and Glycolytic Assessment of the Whole-Body Bone Marrow Compartment.Evaluation of Dual Time Point Imaging 18F-FDG PET/CT in Differentiating Malignancy From Benign Gastric DiseaseComputerized PET/CT image analysis in the evaluation of tumour response to therapy.Evaluation of 18F-FDG uptake for detecting lymph node metastasis of gastric cancer: a prospective pilot study for one-to-one comparison of radiation dose and pathological findings.Positron emission tomography with [(18)F]-3'-deoxy-3'fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot studyEvaluation of FLT-PET/CT usefulness in diagnosis and qualification for surgical treatment of gastric cancer.The Value of PET Imaging in Patients with Localized Gastroesophageal Cancer.Adjuvant treatment for gastric cancer: chemotherapy versus radiationEvaluation of 18F-fluorothymidine positron emission tomography ([18F]FLT-PET/CT) methodology in assessing early response to chemotherapy in patients with gastro-oesophageal cancer.(18)F-FLT PET/CT in Patients with Gastric Carcinoma.Gastric cancer: surgery in 2011.Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies.Surgical approaches to gastric cancer.Role of imaging in predicting response to neoadjuvant chemotherapy in gastric cancer.Current clinical status of 18F-FLT PET or PET/CT in digestive and abdominal organ oncology.Comparison of FLT-PET/CT and CECT in gastric cancer diagnosis.Assessment of (18)F-fluorodeoxyglucose positron emission tomography combined with computed tomography in the preoperative management of patients with gastric cancer.Molecular imaging of proliferation and glucose utilization: utility for monitoring response and prognosis after neoadjuvant therapy in locally advanced gastric cancer.Preclinical evaluation of a novel c-Met inhibitor in a gastric cancer xenograft model using small animal PET.18-Fluorodeoxy-Glucose Positron Emission Tomography- Computed Tomography (18-FDG-PET/CT) for Gross Tumor Volume (GTV) Delineation in Gastric Cancer RadiotherapyANG1005 for breast cancer brain metastases: correlation between 18F-FLT-PET after first cycle and MRI in response assessment.Impact of pretherapeutic routine clinical staging for the individualization of treatment in gastric cancer patients.FLT-PET/CT diagnosis of primary and metastatic nodal lesions of gastric cancer: comparison with FDG-PET/CT.Positron emission tomography/CT versus MRI in liver metastasis: Is there a winner?
P2860
Q26766098-10597788-9528-4F6F-B301-9E20DC6FA054Q26799748-3C935A60-E65E-4811-894E-AB907F4A2155Q27021223-17FEEA33-62BD-4E2B-97FC-ED261DEB1B13Q33728359-62C9F7E5-B2DF-4801-AC24-F96D3BCE4452Q33840377-162C740F-53CA-4212-B619-2FA2C18E85DAQ34039278-1DD70EF6-48BC-4D69-A75D-82336540C551Q34661633-2CCB545E-8F58-4361-B633-6DDD2E349A53Q35336183-1F56B439-CC54-4FEE-95B1-6E49E5FEF30CQ35591525-3563A2CA-16C9-4F87-BDD4-106797AE8FFCQ35724980-BBF2434B-47BB-4AD8-91A0-9DF50BC4F084Q36038787-2E721B0D-B1F4-4A49-B969-AE49E14D7DD9Q36194121-7ECC7D1E-14BA-46A8-8D8E-52A1DEA5748FQ36295403-1EDDD384-519E-4CF9-810E-877F94045CBDQ36340775-50A87471-AEE7-4D0E-B879-3FF097BD6A9FQ36861827-CA5F6D1C-45A4-4836-90E6-0BEDF92628EFQ36936849-7601E18B-789B-46E1-B6BE-FCAB76EFCCD8Q37076617-C37487D0-1E44-48F7-B344-F1A2CD8142F4Q37191333-7A4FDBFF-F65E-470A-BA04-FEBDD8BF9F60Q37418581-4143FF9F-C46A-46AE-9E2E-40AA3C19F84FQ37455530-80C753C7-56B7-4313-821B-975F1F461E24Q37828465-4DB74D20-F21E-4BA1-AFD4-F913858530AFQ37968594-83195FCD-25E5-423A-AEFC-5A15AC447D47Q38016802-B86B58EF-6CE5-4F3C-96EF-B5F5736002A9Q38192620-A14CED99-0185-43E6-8B7E-E8CD9EA96280Q38988008-1B62791B-11F5-4902-A856-30496E33FE65Q40041847-C2DB682E-70C5-473D-BB25-CE0EBEF80577Q44887860-49D44891-FCE9-4634-B5BE-41B344001611Q46961137-AF316507-B2F3-460E-A928-1A67B893D05DQ47302253-623A4920-87FD-4214-B2A1-56E387DF886FQ47418845-697BB671-E801-4030-BE79-789FF4F67023Q48517118-29B22C85-7B12-410A-ACD3-00D92260F921Q51032348-C4F7BAC8-573F-457D-9EB4-B85772805E75Q52982567-724409D0-CEF4-4B98-9E72-481695A1E328Q57817232-F7ECA5F3-10DD-44BC-81E8-FE7635CE4640
P2860
Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Imaging gastric cancer with PE ...... F-FDG: a comparative analysis.
@en
Imaging gastric cancer with PE ...... F-FDG: a comparative analysis.
@nl
type
label
Imaging gastric cancer with PE ...... F-FDG: a comparative analysis.
@en
Imaging gastric cancer with PE ...... F-FDG: a comparative analysis.
@nl
prefLabel
Imaging gastric cancer with PE ...... F-FDG: a comparative analysis.
@en
Imaging gastric cancer with PE ...... F-FDG: a comparative analysis.
@nl
P2093
P1476
Imaging gastric cancer with PE ...... F-FDG: a comparative analysis.
@en
P2093
Bernd J Krause
Dirk Wilhelm
Florian Lordick
Hans-Jürgen Wester
Jörg R Siewert
Karen Becker
Ken Herrmann
Michael Souvatzoglou
Tibor Schuster
P304
P356
10.2967/JNUMED.107.044867
P407
P577
2007-11-15T00:00:00Z